Search for:

Search Medicine or Company Name Search Full Document

Advanced Search

Alliance Pharmaceuticals
Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB Telephone: +44 (0)1249 466 966 Fax: +44 (0)1249 466 977 WWW: http://www.alliancepharma.co.uk Medical Information e-mail: medinfo@alliancepharma.co.uk Need to contact this company?

Summary of Product Characteristics last updated on the eMC: 29/09/2008

SPC

Acnisal

Table of Contents

1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of interaction
4.6 Pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
5.2 Pharmacokinetic properties
5.3 Preclinical safety data
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
6.2 Incompatibilities
6.3 Shelf life
6.4 Special precautions for storage
6.5 Nature and contents of container
6.6 Special precautions for disposal and other handling
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT

Go to top of the page

1. NAME OF THE MEDICINAL PRODUCT

Acnisal 2%w/w Cutaneous Solution

Go to top of the page

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Salicylic acid 2.0% w/w.

For excipients, see 6.1.

Go to top of the page

3. PHARMACEUTICAL FORM

Cutaneous solution

An opaque off-white cutaneous emollient solution.

Go to top of the page

4. CLINICAL PARTICULARS

Go to top of the page

4.1 Therapeutic indications

Acnisal is for the management of acne. It helps prevent new comedones (blackheads and whiteheads) papules and pustules (acne pimples).

Go to top of the page

4.2 Posology and method of administration

For topical administration.

Adults:

Acnisal is used to wash the affected area 2 to 3 times daily. Lather with warm water, massage into skin, rinse and dry.

Children:

As for adults.

Elderly:

As for adults.

Go to top of the page

4.3 Contraindications

Acnisal is contra-indicated in persons with a sensitivity to salicylic acid.

Go to top of the page

4.4 Special warnings and precautions for use

For external use only. Avoid contact with the mouth, eyes and other mucous membranes to avoid irritation.

As with other topical preparations containing salicylic acid, excessive prolonged use may result in symptoms of salicylism.

Go to top of the page

4.5 Interaction with other medicinal products and other forms of interaction

None known.

Go to top of the page

4.6 Pregnancy and lactation

No limitations to the use of Acnisal during pregnancy or lactation are known.

Go to top of the page

4.7 Effects on ability to drive and use machines

None known.

Go to top of the page

4.8 Undesirable effects

Salicylic acid is a mild irritant and may cause skin irritation. If undue skin irritation develops or increases adjust the usage schedule or consult your physician.

Go to top of the page

4.9 Overdose

Not applicable.

Go to top of the page

5. PHARMACOLOGICAL PROPERTIES

Go to top of the page

5.1 Pharmacodynamic properties

Human comedones, naturally or coal tar induced, are firmly anchored and are dislodged with great difficulty. Most classic "peeling" agents are ineffective: they are merely irritants which cause scaling, creating the illusion of comedolysis. While salicylic acid is an irritant its efficacy is dependent on specific pharmacological effects. It seems to detach horny cells from each other by weakening the intercellular cement. As a result, the comedones tend to undergo disorganisation. The effect is probably a good deal more complex. Salicylic acid penetrates skin readily and increases turnover which also favours exfoliation of the comedo. In concentrations of 0.5 to 2% it significantly reduces the formation of microcomedones, which are the precursors of all other acne lesions.

Go to top of the page

5.2 Pharmacokinetic properties

There is no evidence of any systemic absorption from the use of Acnisal.

Go to top of the page

5.3 Preclinical safety data

None presented.

Go to top of the page

6. PHARMACEUTICAL PARTICULARS

Go to top of the page

6.1 List of excipients

Purified water

Benzyl alcohol